Description: Pharmaceutical Drug Rep Advertising Marketing: Byetta (Exenatide Injestion) The Byetta pen (generic: exenatide) is an injectable incretin mimetic diabetes medication that helps control blood sugar levels in patients with type 2 diabetes. The drug works by helping the pancreas produce insulin more effectively. Byetta is made by AstraZeneca, and was first approved by the U.S. Food & Drug Administration (FDA) in April 2005 Byetta is part of a category of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which includes Wegovy, Ozempic, Trulicity, and other medications. Originally developed to treat type 2 diabetes by lowering blood sugar levels, these diabetes drugs can also lead to weight loss. New in box Hard to find Note pad holder, desk organizer for doctor’s office. Never used. This item was given to doctor’s office to help market and promote the medication. Lawsuits are pending today. Byetta has been linked to serious side effects including pancreatic cancer, thyroid cancer, acute hemorrhagic pancreatitis and necrotizing pancreatitis. This hard to find desk collectable item could be used today or put in a drug rep / pharmaceutical rep collection.
Price: 49.78 USD
Location: Collegeville, Pennsylvania
End Time: 2024-10-06T02:11:01.000Z
Shipping Cost: N/A USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
Modified Item: No
